JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
KALA BIO
KALA
$7.45M
| $4.15M | ﹤0.01% |
90
+20
| +29% | +$936K |
2017 Q3
1 quarter
|
|
|
PR
2702
Permian Resources
PR
$18.5B
| $4.15M | ﹤0.01% |
209,754
+67,693
| +48% | +$1.31M |
2017 Q2
2 quarters
|
|
2703
Vishay Precision Group
VPG
$1.05B
| $4.15M | ﹤0.01% |
164,991
+108,791
| +194% | +$2.75M |
2015 Q4
8 quarters
|
|
2704
PUT
McDonald's
MCD
$164B
| $4.15M | ﹤0.01% |
24,100
| – | – |
2013 Q2
18 quarters
|
|
|
FBC
2705
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $4.14M | ﹤0.01% |
110,719
+11,683
| +12% | +$429K |
2013 Q2
18 quarters
|
|
|
DX
2706
Dynex Capital
DX
$2.73B
| $4.14M | ﹤0.01% |
196,886
+140,042
| +246% | +$3M |
2016 Q4
4 quarters
|
|
2707
Varonis Systems
VRNS
$5.46B
| $4.13M | ﹤0.01% |
254,937
+149,202
| +141% | +$2.34M |
2014 Q1
15 quarters
|
|
2708
CALL
Canadian National Railway
CNI
$72.4B
| $4.13M | ﹤0.01% |
+50,000
| New | +$4.03M |
2017 Q4
0 quarters
|
|
2709
TTEC Holdings
TTEC
$68M
| $4.12M | ﹤0.01% |
102,208
-25,934
| -20% | -$1.07M |
2015 Q4
8 quarters
|
|
|
JUNO
2710
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $4.11M | ﹤0.01% |
+90,000
| New | +$4.49M |
2017 Q4
0 quarters
|
|
2711
Mercury Systems
MRCY
$5.17B
| $4.11M | ﹤0.01% |
79,959
+39,878
| +99% | +$2.05M |
2016 Q2
6 quarters
|
|
2712
Western Midstream Partners
WES
$18.5B
| $4.1M | ﹤0.01% |
110,344
+38,566
| +54% | +$1.46M |
2015 Q1
11 quarters
|
|
|
PPBI
2713
DELISTED
Pacific Premier Bancorp
PPBI
| $4.09M | ﹤0.01% |
102,373
+100,514
| +5,407% | +$3.96M |
2016 Q4
4 quarters
|
|
|
SNBR
2714
PUT
DELISTED
Sleep Number
SNBR
| $4.09M | ﹤0.01% |
+108,900
| New | +$3.71M |
2017 Q4
0 quarters
|
|
2715
CALL
General Dynamics
GD
$89.3B
| $4.09M | ﹤0.01% |
20,100
+3,700
| +23% | +$756K |
2016 Q3
5 quarters
|
|
|
CNCE
2716
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.09M | ﹤0.01% |
+158,066
| New | +$3.18M |
2017 Q4
0 quarters
|
|
2717
Merit Medical Systems
MMSI
$5.1B
| $4.09M | ﹤0.01% |
94,622
+9,307
| +11% | +$390K |
2016 Q2
6 quarters
|
|
2718
PUT
Adobe
ADBE
$94.5B
| $4.08M | ﹤0.01% |
23,300
-147,000
| -86% | -$25.3M |
2017 Q1
3 quarters
|
|
2719
PUT
F5
FFIV
$25.7B
| $4.07M | ﹤0.01% |
31,000
| – | – |
2017 Q3
1 quarter
|
|
2720
PUT
Bath & Body Works
BBWI
$3.24B
| $4.06M | ﹤0.01% |
83,374
+24,740
| +42% | +$1,000K |
2017 Q1
3 quarters
|
|
|
EFF
2721
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| $4.06M | ﹤0.01% |
248,734
+3,409
| +1% | +$55.9K |
2014 Q3
13 quarters
|
|
2722
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.19B
| $4.05M | ﹤0.01% |
95,498
+701
| +0.7% | +$29.4K |
2016 Q1
7 quarters
|
|
2723
Innospec
IOSP
$2.4B
| $4.05M | ﹤0.01% |
57,374
-18,412
| -24% | -$1.23M |
2013 Q2
18 quarters
|
|
2724
Northwest Bancshares
NWBI
$2.22B
| $4.05M | ﹤0.01% |
242,010
+87,100
| +56% | +$1.46M |
2015 Q4
8 quarters
|
|
|
HMTV
2725
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $4.05M | ﹤0.01% |
350,463
+347,357
| +11,183% | +$4.09M |
2016 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.